To evaluate the utility of SYNGR3 as a novel prognostic immune cell biomarker of HPV(+) HNSC, we used the UCSC Xenabrowser to analyze publicly available RNA-seq data for TCGA head and neck cancer dataset (94). The gene discussed is SYNGR3; the disease is head and neck cancer.